CD4 and Hodgkins lymphoma: These parameters, including CD3+CD4+HLA-DR+ T cells (odds ratio [OR] =1.190, 95% CI 1.067–1.328, p = 0.002) and CD3+CD8+HLA-DR+ T cells (OR = 1.235, 95% CI 1.071–1.426, p = 0.004), were associated with NCR in HL (Tables 2, 3).